The International Journal of Cardiology is a global journal of cardiology, cardio-metabolic and vascular sciences. Articles reporting clinical observations and interventions, experimental studies and theoretical concepts are all welcome provided they are of major scientific importance and clinical relevance. The journal covers all aspects of cardiology from genes to populations. The journal commissions high quality review articles from distinguished authors. Submission of a manuscript to this journal gives the publisher the right to publish that paper if it is accepted. Manuscripts may be edited to improve clarity and expression INTRODUCTION
The International Journal of Cardiology is a global journal of cardiology that welcomes the following types of articles:
New Paediatric cardiology section
Text in these articles should not exceed 3,500 words, 50 references and 4 tables/figures. Additional references and/or methods will be published online only.
This category includes the following types of articles:
Original clinical research studies, basic science/translational research papers:
International Journal of Cardiology publishes articles highlighting all aspects of cardiovascular disease, including original clinical studies in the fields of clinical investigation, pharmacotherapy, genetics, cardiovascular imaging, intervention, structural heart disease, etc.- clinical trials, meta-analyses, pathophysiological investigations, experimental studies with clinical relevance and state-of-the-art papers. Cardiovascular basic science research studies with a strong clinical translational component will be considered for publication. Basic science papers usually depict research carried out in experimental animals, cells, or tissue. The abstract section of these papers should include a paragraph or two (50-75 words) describing the translational aspect of the work.
Consensus and Position Papers
Usually produced by recognized institutions or working groups these articles provide expert opinion on topical issues in cardiovascular medicine and related disciplines which are of high interest and potential value for the practicing cardiologist as well as regulatory agencies, national and international societies and Society in general. These articles generally deal with issues that are not specifically covered by current international guidelines and therefore constitute unmet needs.
Systematic reviews and meta-analyses
These manuscripts are systematic assessments of the evidence available in the medical literature regarding specific issues, including pathophysiological mechanisms, diagnosis, prognosis, disease treatment, preventative management, etc. An established methodology exists for the production of these articles. For advice on systematic review preparation consult the Cochrane Reviewers' Handbook.
Short communication should contain original data as per the description given under "original articles" but their length should not exceed 1,500 words; 20 references; 2 figures/tables. Case reports are not acceptable under this category.
This manuscript category may include clinical studies/high quality observational work - either clinical or experimental - reflecting novel preliminary findings or results of studies that can be summarised in under 1500 words. These articles may be hypothesis generating and/or able to stimulate research in a specific area. A structured abstract (around 200 words) is required and the article should be structured in the same fashion as original papers. Illustrative figures are welcome.
Editorial articles are commissioned by the Editor-in-Chief and aim to provide brief expert views on specific manuscripts published in a given IJC issue. These articles should contain a max. of 1,000 words; 10 references; 1 figure/table
This new section aims to publish high-quality original research articles, invited and unsolicited reviews and short communications in the field of paediatric cardiology. All aspects of cardiovascular medicine in infants, children and adolescents, including fetal cardiology, inherited cardiac conditions and acquired heart disease, are covered within this section. We encourage work on clinical paediatric cardiology subspecialties, including electrophysiology, interventional cardiology, cardiac imaging and cardiogenetics. Submissions on basic and fundamental science as they relate to paediatric heart disease, including cardiomyocyte biology, pharmacology and biochemistry, are also highly welcome. New Sports Cardiology section
This new section will accept for publication original articles, invited and unsolicited reviews, and short communications related to Sports Cardiology which is a new and rapidly evolving subspeciality.
Main issues include the evaluation of the effects of regular exercise on the heart (athlete's heart), the interpretation of the athlete?s ECG and imaging findings, the differential diagnosis between cardiomyopathies and athlete?s heart and the assessment of sports-related cardiovascular risks in athletes with coronary artery or myocardial diseases that may predispose to sudden cardiac death during sports.
Other potential topics include the implementation of preventive strategies such as pre-participation cardiovascular screening aimed at the identification of at-risk athletes and programs of early defibrillation by automated external defibrillator in the sports arena. Letters to the Editor
The content of a letter to the Editor must relate
to a specific article
published in IJC; max 250
figures/tables. We only accept Letters to the Editor that challenge previously published articles in the International Journal of Cardiology
by raising specific questions and/or concerns that authors of the referenced paper can be invited to address.
No more of three Letters to the Editor from the same author(s) can be published in our Journal in one year. Commentary
To provide our readership with both new and high-quality content, we have introduced a new article type called ‘Commentary’, i.e. brief articles commissioned by the Editor in Chief and the Deputy Editors that would highlight and discuss the best studies published in our Journal, in selected fields. Each article should consist of a maximum of 1500
words, up to 10
references and a maximum of 2
figures. Invited Reviews
This is upon invitation only.
Each article should consist of a maximum of 3500
words, up to 50
references and a maximum of 4
Additional references and/or methods will be published online only.Unsolicited Reviews Under this article type, the Editor-in-Chief of IJC encourages the submission of any narrative, systematic reviews, or metanalysis that would focus on new and innovative topics.
Topics may include but are not limited to Congenital Heart Disease, Rare cardiomyopathies, and Microvascular Dysfunctions. Any other topic not been explored in the past 6 -12 months in published reviews is welcome. Both clinical and basic science topics are accepted with special emphasis on pathophysiology and mechanisms of disease. Originality is key as well as citation of relevant existing literature. An explanatory, high-quality, central illustration, is mandatory. We inform authors that for this type of review there is no need for an editorial invitation, please select "unsolicited review" from the dropdown menu at the submission stage.
Format Requirements: 3,500
references, and one
central illustration. Additional References, tables, and/or figures can be included as supplementary material.PREPARATION OF MANUSCRIPTS: Original articles and Short communication
should be structured as following:
Divide the manuscript into the following sections: Title page, Structured Abstract, Key words (3-6), Introduction, Methods, Results, Discussion, Acknowledgments, References. The editors will consider the use of other sections if more suitable for certain manuscripts. Type double-spaced. The Title Page should include: 1. The title (not to exceed 25 words) 2. The full list of authors and for each author a numbered footnote. The footnote should state the author's academic affiliation and the following statement of authorship: "This author takes responsibility for all aspects of the reliability and freedom from bias of the data presented and their discussed interpretation". Any author unable to make this statement must instead state their specific contribution to the manuscript. 3. Corresponding author and contact details 4. Acknowledgement of grant support 5. Any potential conflicts of interest, including related consultancies, shareholdings and funding grants 6. A list of up to 6 keywords The Next Page Should Include:
A Structured Abstract, of no more than 250 words. As this may be the only part of the article read by some readers it must include sufficient detail for an adequate summary of the whole manuscript. The preferred subheadings are Background, Methods, Results and Conclusions, although a merged Methods and Results subheading is also permitted if this permits more economical expression. The Next Page should commence the main article subdivided into the following sections:
The Introduction should be brief and set out why the study has been performed along with a review of relevant previous work only where essential.
The Methods should be sufficiently detailed so that readers and reviewers can understand precisely what has been done. Standard methods can be referenced. Manuscripts reporting data obtained from research conducted in human subjects must include a statement of assurance in the Methods section of the manuscript that (1) informed consent was obtained from each patient and (2) the study protocol conforms to the ethical guidelines of the 1975 Declaration of Helsinki as reflected in a priori approval by the institution's human research committee. Manuscripts reporting experiments using animals must include a statement giving assurance that all animals received humane care and that study protocols comply with the institution's guidelines.
A Statistical Methods Section must be included where relevant. This should include the statistical methods used with sufficient clarity for the findings to be reproduced by independent analysis of the dataset, a statement on how the data presented were selected including prospective sample size calculations, the reasons for including/excluding subjects or data points, and what steps the authors have taken, if any, to exclude intentional or unintentional bias in recruitment, measurement, data retention, analysis, reporting and comment.
The Results should be presented precisely. Keep discussion of their importance to a minimum in this section of the manuscript. Present 95% confidence intervals with p values. When describing normal distributions, denote the standard deviation explicitly, e.g. with the abbreviation SD, rather than a ? sign. When describing uncertainty of a mean, denote the standard error of the mean explicitly, e.g. with the abbreviation SEM, rather than a ? sign. It is a condition of final acceptance of manuscripts, for the purpose of scientific integrity, that for each figure, raw numerical values should be uploaded in an Online Data Supplement. These supplement files should be one or more standard spreadsheet files. Raw x and y values for all scatterplots should be given. For bar charts and histograms, underlying raw values and categories should be given. For each Kaplan-Meier survival curve, for each patient a time-to-event-or-censoring and censor status should be given. Authors may additionally optionally upload comprehensive numerical datasets of the study.
The Discussion should directly relate to the study being reported rather than a general review of the topic.
A Study limitations subsection must be included and should disclose any reasons the findings may not be applicable more broadly.
Conclusions should be limited to a brief summary and the implications of the data presented.
References Discoverability of research and high quality peer review are ensured by online links to the sources cited. In order to allow us to create links within ScienceDirect and to abstracting and indexing services, such as Scopus, CrossRef or PubMed, please ensure that data provided in the references are correct. Please note that incorrect surnames, journal/book titles, publication year and pagination may prevent the link creation. When copying references, please be careful as they may already contain an error.
There are no strict requirements on reference formatting at submission. References can be in any style or format as long as the style is consistent. Author(s) name(s), journal title/book title, chapter title/article title, year of publication, volume and issue/book chapter and the pagination must be present. The reference style used by the journal will be applied to the accepted article by Elsevier at the proof stage. Note that incorrect or missing data will be highlighted at proof stage for the author to correct.The reference style used by this journal is Vancouver Numbered. If you do wish to format the references yourself they should be arranged according to the following examples Examples:  De Soyza N, Thenabadu PN, Murphy ML, Kane JJ, Doherty JE. Ventricular arrhythmia before and after aortocoronary bypass surgery. Int J Cardiol 1981; 1:123-130.  Akutsu T. Artificial heart: total replacement and partial support. Amsterdam: Elsevier/North-Holland, 1975.  Goldman RH. Digitalis toxicity. In: Bristow MR, editors. Drug-induced heart disease. Amsterdam: Elsevier/North-Holland, 1980:217-40.
Please note that all authors should be listed when six or less; when seven or more, list only the first three and add et al. Do not include references to personal communications, unpublished data or manuscripts either "in preparation" or "submitted for publication". If essential, such material may be incorporated into the appropriate place in the text. Recheck references in the text against reference list after your manuscript has been revised.
Tables should be typed with double spacing and each should be on a separate sheet. They should be numbered consecutively with Arabic numerals, and contain only horizontal lines. Provide a short descriptive heading above each table with footnotes and/or explanations underneath. Figures should ideally be submitted in high-resolution TIF format, or alternatively in GIF, JPEG/JPG, or EPS format. The figures should be placed in separate files, named only with the figure numbers (e.g. "Figure1.tif".) The cost of colour figures will be paid by the author.
Please ensure figures have the appropriate resolution: Line art: 1000 dpi Halftones: 300 dpi Combinations: 500 dpi Colour: 300 dpi Colour combinations: 500 dpi.
Figures can appear in colour in the online journal at no additional cost to the author, but if the author requires the paper journal to show the figures in colour there is an additional cost to pay.
For further information on the preparation of electronic artwork, please seehttp://authors.elsevier.com/artwork. Legends for Figures should be typed with double-spacing on a separate sheet.
For each and every gene accession number cited in an article, authors should type the accession number in bold, underlined text. Letters in the accession number should always be capitalised. Example: (GenBank accession nos. AI631510, AI631511, AI632198, and BF223228,) a B-cell tumor from a chronic lymphatic leukemia (GenBank accession no. BE675048,) and a T-cell lymphoma (GenBank accession no. AA361117). Process of Submission
The International Journal of Cardiology is a fully electronic journal. All manuscripts MUST be submitted via the Internet to the following Elsevier website: https://www.editorialmanager.com/IJCJOURNAL/default.aspx
. DO NOT email the manuscript to the journal or editors.
Author Agreement Form All authors and contributors must submit a form stating their role in the article. The link to the form is available in the Attach file section in the submission system. The International Journal of Cardiology requires all authors to sign this form. Articles will not be published until these are received.
Changes to Authorship This policy concerns the addition, deletion, or rearrangement of author names in the authorship of accepted manuscripts: Before the accepted manuscript is published in an online issue: Requests to add or remove an author, or to rearrange the author names, must be sent to the Journal Manager from the corresponding author of the accepted manuscript and must include: (a) the reason the name should be added or removed, or the author names rearranged and (b) written signed confirmation from ALL authors that they agree with the addition, removal or rearrangement. In the case of addition or removal of authors, this includes confirmation from the author being added or removed. Requests that are not sent by the corresponding author will be forwarded by the Journal Manager to the corresponding author, who must follow the procedure as described above.
Note that: (1) Journal Managers will inform the Journal Editors of any such requests and (2) publication of the accepted manuscript in an online issue is suspended until authorship has been agreed. After the accepted manuscript is published in an online issue: Any requests to add, delete, or rearrange author names in an article already published online must follow the same policies as noted above. If accepted, the change will be noted by the publication of a corrigendum.
Preparation of supplementary data International Journal of Cardiology publishes electronic supplementary material to enhance your scientific research presentation, increase transparency, and support scientific integrity. It is required that raw data for figures should be presented, and the author is invited voluntarily to publish in full the detailed dataset of the study. Supplementary files may also include supporting applications, movies, animation sequences, high-resolution images, background datasets, sound clips or other helpful items. Supplementary files supplied will be published online alongside the electronic version of your article in Elsevier web products, including ScienceDirect: http://www.sciencedirect.com
Language Editing The language of the Journal is English. International Science Editing and Asia Science Editing can provide English language and copyediting services to authors who want to publish in scientific, technical and medical journals and need assistance before they submit their article or, before it is accepted for publication. Authors can contact these services directly: International Science Editing (http://www.internationalscienceediting.com
) and Asia Science Editing (http://www.asiascienceediting.com
) or, for more information about language editing services, please visit our Support Center
. Page charges
Page Charges will not be levied. Submission checklist
You can use this list to carry out a final check of your submission before you send it to the journal for review. Please check the relevant section in this Guide for Authors for more details. Ensure that the following items are present:
One author has been designated as the corresponding author with contact details:
• E-mail address
• Full postal address
All necessary files have been uploaded:Manuscript
• Include keywords
• All figures (include relevant captions)
• All tables (including titles, description, footnotes)
• Ensure all figure and table citations in the text match the files provided
• Indicate clearly if color should be used for any figures in printGraphical Abstracts / Highlights files
(where applicable)Supplemental files
• Manuscript has been 'spell checked' and 'grammar checked'
• All references mentioned in the Reference List are cited in the text, and vice versa
• Permission has been obtained for use of copyrighted material from other sources (including the Internet)
• A competing interests statement is provided, even if the authors have no competing interests to declare
• Journal policies detailed in this guide have been reviewed
• Referee suggestions and contact details provided, based on journal requirements
For further information, visit our Support Center
. Ethics in publishing
Please see our information on Ethics in publishing
. Studies in humans and animals
If the work involves the use of human subjects, the author should ensure that the work described has been carried out in accordance with The Code of Ethics of the World Medical Association
(Declaration of Helsinki) for experiments involving humans. The manuscript should be in line with the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals
and aim for the inclusion of representative human populations (sex, age and ethnicity) as per those recommendations. The terms sex and gender
should be used correctly.
Authors should include a statement in the manuscript that informed consent was obtained for experimentation with human subjects. The privacy rights of human subjects must always be observed.
All animal experiments should comply with the ARRIVE guidelines
and should be carried out in accordance with the U.K. Animals (Scientific Procedures) Act, 1986 and associated guidelines, EU Directive 2010/63/EU for animal experiments
, or the National Research Council's Guide for the Care and Use of Laboratory Animals
and the authors should clearly indicate in the manuscript that such guidelines have been followed. The sex of animals must be indicated, and where appropriate, the influence (or association) of sex on the results of the study. Informed consent and patient details
Studies on patients or volunteers require ethics committee approval and informed consent, which should be documented in the paper. Appropriate consents, permissions and releases must be obtained where an author wishes to include case details or other personal information or images of patients and any other individuals in an Elsevier publication. Written consents must be retained by the author but copies should not be provided to the journal. Only if specifically requested by the journal in exceptional circumstances (for example if a legal issue arises) the author must provide copies of the consents or evidence that such consents have been obtained. For more information, please review the Elsevier Policy on the Use of Images or Personal Information of Patients or other Individuals
. Unless you have written permission from the patient (or, where applicable, the next of kin), the personal details of any patient included in any part of the article and in any supplementary materials (including all illustrations and videos) must be removed before submission. Declaration of interest
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. Examples of potential competing interests include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. Authors must disclose any interests in two places: 1. A summary declaration of interest statement in the title page file (if double anonymized) or the manuscript file (if single anonymized). If there are no interests to declare then please state this: 'Declarations of interest: none'. 2. Detailed disclosures as part of a separate Declaration of Interest form, which forms part of the journal's official records. It is important for potential interests to be declared in both places and that the information matches. More information
Conflict of interest statements for authors
All authors are requested to disclose any actual or potential conflict of interest including any financial, personal or other relationships with other people or organizations within three years of beginning the submitted work that could inappropriately influence, or be perceived to influence, their work. See also https://www.elsevier.com/conflictsofinterest
The International Journal of Cardiology requires full disclosure of all potential conflicts of interest.The form is available under the section Declaration of interest
Potential Conflicts of Interest Related to Individual Authors' Commitments When authors submit a manuscript, whether an article or a letter, they are responsible for disclosing all financial and personal relationships that might bias their work. To prevent ambiguity, authors must state explicitly whether potential conflicts do or do not exist.
Further information and an example of a Conflict of Interest form can be found at: https://service.elsevier.com/app/answers/detail/a_id/286/supporthub/publishing Declaration of generative AI in scientific writing
The below guidance only refers to the writing process, and not to the use of AI tools to analyse and draw insights from data as part of the research process.
Where authors use generative artificial intelligence (AI) and AI-assisted technologies in the writing process, authors should only use these technologies to improve readability and language. Applying the technology should be done with human oversight and control, and authors should carefully review and edit the result, as AI can generate authoritative-sounding output that can be incorrect, incomplete or biased. AI and AI-assisted technologies should not be listed as an author or co-author, or be cited as an author. Authorship implies responsibilities and tasks that can only be attributed to and performed by humans, as outlined in Elsevier’s AI policy for authors
Authors should disclose in their manuscript the use of AI and AI-assisted technologies in the writing process by following the instructions below. A statement will appear in the published work. Please note that authors are ultimately responsible and accountable for the contents of the work.Disclosure instructions
Authors must disclose the use of generative AI and AI-assisted technologies in the writing process by adding a statement at the end of their manuscript in the core manuscript file, before the References list. The statement should be placed in a new section entitled ‘Declaration of Generative AI and AI-assisted technologies in the writing process’.Statement: During the preparation of this work the author(s) used [NAME TOOL / SERVICE] in order to [REASON]. After using this tool/service, the author(s) reviewed and edited the content as needed and take(s) full responsibility for the content of the publication.
This declaration does not apply to the use of basic tools for checking grammar, spelling, references etc. If there is nothing to disclose, there is no need to add a statement. Submission declaration and verification
Submission of an article implies that the work described has not been published previously (except in the form of an abstract, a published lecture or academic thesis, see 'Multiple, redundant or concurrent publication'
for more information), that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere in the same form, in English or in any other language, including electronically without the written consent of the copyright-holder. To verify compliance, your article may be checked by Crossref Similarity Check
and other originality or duplicate checking software. Preprints
Please note that preprints
can be shared anywhere at any time, in line with Elsevier's sharing policy
. Sharing your preprints e.g. on a preprint server will not count as prior publication (see 'Multiple, redundant or concurrent publication
' for more information). Preprint posting on SSRN
In support of Open Science
, this journal offers its authors a free preprint posting service. Preprints provide early registration and dissemination of your research, which facilitates early citations and collaboration.
During submission to Editorial Manager, you can choose to release your manuscript publicly as a preprint on the preprint server SSRN
once it enters peer-review with the journal. Your choice will have no effect on the editorial process or outcome with the journal. Please note that the corresponding author is expected to seek approval from all co-authors before agreeing to release the manuscript publicly on SSRN.
You will be notified via email when your preprint is posted online and a Digital Object Identifier (DOI) is assigned. Your preprint will remain globally available free to read whether the journal accepts or rejects your manuscript.
For more information about posting to SSRN
. Use of inclusive language
Inclusive language acknowledges diversity, conveys respect to all people, is sensitive to differences, and promotes equal opportunities. Content should make no assumptions about the beliefs or commitments of any reader; contain nothing which might imply that one individual is superior to another on the grounds of age, gender, race, ethnicity, culture, sexual orientation, disability or health condition; and use inclusive language throughout. Authors should ensure that writing is free from bias, stereotypes, slang, reference to dominant culture and/or cultural assumptions. We advise to seek gender neutrality by using plural nouns ("clinicians, patients/clients") as default/wherever possible to avoid using "he, she," or "he/she." We recommend avoiding the use of descriptors that refer to personal attributes such as age, gender, race, ethnicity, culture, sexual orientation, disability or health condition unless they are relevant and valid. When coding terminology is used, we recommend to avoid offensive or exclusionary terms such as "master", "slave", "blacklist" and "whitelist". We suggest using alternatives that are more appropriate and (self-) explanatory such as "primary", "secondary", "blocklist" and "allowlist". These guidelines are meant as a point of reference to help identify appropriate language but are by no means exhaustive or definitive. Reporting sex- and gender-based analysesReporting guidance
For research involving or pertaining to humans, animals or eukaryotic cells, investigators should integrate sex and gender-based analyses (SGBA) into their research design according to funder/sponsor requirements and best practices within a field. Authors should address the sex and/or gender dimensions of their research in their article. In cases where they cannot, they should discuss this as a limitation to their research's generalizability. Importantly, authors should explicitly state what definitions of sex and/or gender they are applying to enhance the precision, rigor and reproducibility of their research and to avoid ambiguity or conflation of terms and the constructs to which they refer (see Definitions section below). Authors can refer to the Sex and Gender Equity in Research (SAGER) guidelines
and the SAGER guidelines checklist
. These offer systematic approaches to the use and editorial review of sex and gender information in study design, data analysis, outcome reporting and research interpretation - however, please note there is no single, universally agreed-upon set of guidelines for defining sex and gender.Definitions
Sex generally refers to a set of biological attributes that are associated with physical and physiological features (e.g., chromosomal genotype, hormonal levels, internal and external anatomy). A binary sex categorization (male/female) is usually designated at birth ("sex assigned at birth"), most often based solely on the visible external anatomy of a newborn. Gender generally refers to socially constructed roles, behaviors, and identities of women, men and gender-diverse people that occur in a historical and cultural context and may vary across societies and over time. Gender influences how people view themselves and each other, how they behave and interact and how power is distributed in society. Sex and gender are often incorrectly portrayed as binary (female/male or woman/man) and unchanging whereas these constructs actually exist along a spectrum and include additional sex categorizations and gender identities such as people who are intersex/have differences of sex development (DSD) or identify as non-binary. Moreover, the terms "sex" and "gender" can be ambiguous—thus it is important for authors to define the manner in which they are used. In addition to this definition guidance and the SAGER guidelines, the resources on this page
offer further insight around sex and gender in research studies. Author contributions
For transparency, we encourage authors to submit an author statement file outlining their individual contributions to the paper using the relevant CRediT roles: Conceptualization; Data curation; Formal analysis; Funding acquisition; Investigation; Methodology; Project administration; Resources; Software; Supervision; Validation; Visualization; Roles/Writing - original draft; Writing - review & editing. Authorship statements should be formatted with the names of authors first and CRediT role(s) following. More details and an example
All authors should have made substantial contributions to all of the following: (1) the conception and design of the study, or acquisition of data, or analysis and interpretation of data, (2) drafting the article or revising it critically for important intellectual content, (3) final approval of the version to be submitted. Changes to authorship
Authors are expected to consider carefully the list and order of authors before
submitting their manuscript and provide the definitive list of authors at the time of the original submission. Any addition, deletion or rearrangement of author names in the authorship list should be made only before
the manuscript has been accepted and only if approved by the journal Editor. To request such a change, the Editor must receive the following from the corresponding author
: (a) the reason for the change in author list and (b) written confirmation (e-mail, letter) from all authors that they agree with the addition, removal or rearrangement. In the case of addition or removal of authors, this includes confirmation from the author being added or removed.
Only in exceptional circumstances will the Editor consider the addition, deletion or rearrangement of authors after
the manuscript has been accepted. While the Editor considers the request, publication of the manuscript will be suspended. If the manuscript has already been published in an online issue, any requests approved by the Editor will result in a corrigendum. Clinical trial results
In line with the position of the International Committee of Medical Journal Editors, the journal will not consider results posted in the same clinical trials registry in which primary registration resides to be prior publication if the results posted are presented in the form of a brief structured (less than 500 words) abstract or table. However, divulging results in other circumstances (e.g., investors' meetings) is discouraged and may jeopardise consideration of the manuscript. Authors should fully disclose all posting in registries of results of the same or closely related work. Reporting clinical trials
Randomized controlled trials should be presented according to the CONSORT guidelines. At manuscript submission, authors must provide the CONSORT checklist accompanied by a flow diagram that illustrates the progress of patients through the trial, including recruitment, enrollment, randomization, withdrawal and completion, and a detailed description of the randomization procedure. The CONSORT checklist and template flow diagram
are available online. Registration of clinical trials
Registration in a public trials registry is a condition for publication of clinical trials in this journal in accordance with International Committee of Medical Journal Editors
recommendations. Trials must register at or before the onset of patient enrolment. The clinical trial registration number should be included at the end of the abstract of the article. A clinical trial is defined as any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects of health outcomes. Health-related interventions include any intervention used to modify a biomedical or health-related outcome (for example drugs, surgical procedures, devices, behavioural treatments, dietary interventions, and process-of-care changes). Health outcomes include any biomedical or health-related measures obtained in patients or participants, including pharmacokinetic measures and adverse events. Purely observational studies (those in which the assignment of the medical intervention is not at the discretion of the investigator) will not require registration. Article transfer service
This journal uses the Elsevier Article Transfer Service to find the best home for your manuscript. This means that if an editor feels your manuscript is more suitable for an alternative journal, you might be asked to consider transferring the manuscript to such a journal. The recommendation might be provided by a Journal Editor, a dedicated Scientific Managing Editor
, a tool assisted recommendation, or a combination. If you agree, your manuscript will be transferred, though you will have the opportunity to make changes to the manuscript before the submission is complete. Please note that your manuscript will be independently reviewed by the new journal. More information
Upon acceptance of an article, authors will be asked to complete a 'Journal Publishing Agreement' (see more information
on this). An e-mail will be sent to the corresponding author confirming receipt of the manuscript together with a 'Journal Publishing Agreement' form or a link to the online version of this agreement.
Subscribers may reproduce tables of contents or prepare lists of articles including abstracts for internal circulation within their institutions. Permission
of the Publisher is required for resale or distribution outside the institution and for all other derivative works, including compilations and translations. If excerpts from other copyrighted works are included, the author(s) must obtain written permission from the copyright owners and credit the source(s) in the article. Elsevier has preprinted forms
for use by authors in these cases.
For gold open access articles: Upon acceptance of an article, authors will be asked to complete a 'License Agreement' (more information
). Permitted third party reuse of gold open access articles is determined by the author's choice of user license
As an author you (or your employer or institution) have certain rights to reuse your work. More information
. Elsevier supports responsible sharing
Find out how you can share your research
published in Elsevier journals. Role of the funding source
You are requested to identify who provided financial support for the conduct of the research and/or preparation of the article and to briefly describe the role of the sponsor(s), if any, in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication. If the funding source(s) had no such involvement, it is recommended to state this. Open access
Please visit our Open Access page
for more information. Elsevier Researcher AcademyResearcher Academy
is a free e-learning platform designed to support early and mid-career researchers throughout their research journey. The "Learn" environment at Researcher Academy offers several interactive modules, webinars, downloadable guides and resources to guide you through the process of writing for research and going through peer review. Feel free to use these free resources to improve your submission and navigate the publication process with ease. Language (usage and editing services)
Please write your text in good English (American or British usage is accepted, but not a mixture of these). Authors who feel their English language manuscript may require editing to eliminate possible grammatical or spelling errors and to conform to correct scientific English may wish to use the English Language Editing service
available from Elsevier's Author Services. Submission
Our online submission system guides you stepwise through the process of entering your article details and uploading your files. The system converts your article files to a single PDF file used in the peer-review process. Editable files (e.g., Word, LaTeX) are required to typeset your article for final publication. All correspondence, including notification of the Editor's decision and requests for revision, is sent by e-mail. Submit your article
Please submit your article via https://www.editorialmanager.com/IJCJOURNAL/default.aspx
. Suggesting reviewers
Please submit the names and institutional e-mail addresses of several potential reviewers.
You should not suggest reviewers who are colleagues, or who have co-authored or collaborated with you during the last three years. Editors do not invite reviewers who have potential competing interests with the authors. Further, in order to provide a broad and balanced assessment of the work, and ensure scientific rigor, please suggest diverse candidate reviewers who are located in different countries/regions from the author group. Also consider other diversity attributes e.g. gender, race and ethnicity, career stage, etc. Finally, you should not include existing members of the journal's editorial team, of whom the journal are already aware.
Note: the editor decides whether or not to invite your suggested reviewers. Queries
For questions about the editorial process (including the status of manuscripts under review) or for technical support on submissions, please visit our Support Center
. Peer review
This journal operates a single anonymized review process. All contributions will be initially assessed by the editor for suitability for the journal. Papers deemed suitable are then typically sent to a minimum of two independent expert reviewers to assess the scientific quality of the paper. The Editor is responsible for the final decision regarding acceptance or rejection of articles. The Editor's decision is final. Editors are not involved in decisions about papers which they have written themselves or have been written by family members or colleagues or which relate to products or services in which the editor has an interest. Any such submission is subject to all of the journal's usual procedures, with peer review handled independently of the relevant editor and their research groups. More information on types of peer review
. Use of word processing software
It is important that the file be saved in the native format of the word processor used. The text should be in single-column format. Keep the layout of the text as simple as possible. Most formatting codes will be removed and replaced on processing the article. In particular, do not use the word processor's options to justify text or to hyphenate words. However, do use bold face, italics, subscripts, superscripts etc. When preparing tables, if you are using a table grid, use only one grid for each individual table and not a grid for each row. If no grid is used, use tabs, not spaces, to align columns. The electronic text should be prepared in a way very similar to that of conventional manuscripts (see also the Guide to Publishing with Elsevier
). Note that source files of figures, tables and text graphics will be required whether or not you embed your figures in the text. See also the section on Electronic artwork.
To avoid unnecessary errors you are strongly advised to use the 'spell-check' and 'grammar-check' functions of your word processor. Article structure Subdivision - numbered sections
Divide your article into clearly defined and numbered sections. Subsections should be numbered 1.1 (then 1.1.1, 1.1.2, ...), 1.2, etc. (the abstract is not included in section numbering). Use this numbering also for internal cross-referencing: do not just refer to 'the text'. Any subsection may be given a brief heading. Each heading should appear on its own separate line. Introduction
State the objectives of the work and provide an adequate background, avoiding a detailed literature survey or a summary of the results. Material and methods
Provide sufficient details to allow the work to be reproduced by an independent researcher. Methods that are already published should be summarized, and indicated by a reference. If quoting directly from a previously published method, use quotation marks and also cite the source. Any modifications to existing methods should also be described. Theory/calculation
A Theory section should extend, not repeat, the background to the article already dealt with in the Introduction and lay the foundation for further work. In contrast, a Calculation section represents a practical development from a theoretical basis. Results
Results should be clear and concise. Discussion
This should explore the significance of the results of the work, not repeat them. A combined Results and Discussion section is often appropriate. Avoid extensive citations and discussion of published literature. Conclusions
The main conclusions of the study may be presented in a short Conclusions section, which may stand alone or form a subsection of a Discussion or Results and Discussion section. Appendices
If there is more than one appendix, they should be identified as A, B, etc. Formulae and equations in appendices should be given separate numbering: Eq. (A.1), Eq. (A.2), etc.; in a subsequent appendix, Eq. (B.1) and so on. Similarly for tables and figures: Table A.1; Fig. A.1, etc. Essential title page information
Concise and informative. Titles are often used in information-retrieval systems. Avoid abbreviations and formulae where possible.
• Author names and affiliations.
Please clearly indicate the given name(s) and family name(s) of each author and check that all names are accurately spelled. You can add your name between parentheses in your own script behind the English transliteration. Present the authors' affiliation addresses (where the actual work was done) below the names. Indicate all affiliations with a lower-case superscript letter immediately after the author's name and in front of the appropriate address. Provide the full postal address of each affiliation, including the country name and, if available, the e-mail address of each author.
• Corresponding author.
Clearly indicate who will handle correspondence at all stages of refereeing and publication, also post-publication. This responsibility includes answering any future queries about Methodology and Materials. Ensure that the e-mail address is given and that contact details are kept up to date by the corresponding author.
• Present/permanent address.
If an author has moved since the work described in the article was done, or was visiting at the time, a 'Present address' (or 'Permanent address') may be indicated as a footnote to that author's name. The address at which the author actually did the work must be retained as the main, affiliation address. Superscript Arabic numerals are used for such footnotes. Highlights
Highlights are optional yet highly encouraged for this journal, as they increase the discoverability of your article via search engines. They consist of a short collection of bullet points that capture the novel results of your research as well as new methods that were used during the study (if any). Please have a look at the examples here: example Highlights
Highlights should be submitted in a separate editable file in the online submission system. Please use 'Highlights' in the file name and include 3 to 5 bullet points (maximum 85 characters, including spaces, per bullet point). Abstract
A concise and factual abstract is required. The abstract should state briefly the purpose of the research, the principal results and major conclusions. An abstract is often presented separately from the article, so it must be able to stand alone. For this reason, References should be avoided, but if essential, then cite the author(s) and year(s). Also, non-standard or uncommon abbreviations should be avoided, but if essential they must be defined at their first mention in the abstract itself. Graphical abstract
Although a graphical abstract is optional, its use is encouraged as it draws more attention to the online article. The graphical abstract should summarize the contents of the article in a concise, pictorial form designed to capture the attention of a wide readership. Graphical abstracts should be submitted as a separate file in the online submission system. Image size: Please provide an image with a minimum of 531 × 1328 pixels (h × w) or proportionally more. The image should be readable at a size of 5 × 13 cm using a regular screen resolution of 96 dpi. Preferred file types: TIFF, EPS, PDF or MS Office files. You can view Example Graphical Abstracts
on our information site. Submission of Genetic Information
Every gene, DNA sequence, cell line and polymorphism/variant referred to in an article must adhere to standardized nomenclature as outlined below:
- Only gene names approved by the HUGO Gene Nomenclature Committee should be used: http://www.genenames.org
- All DNA sequences and GenBank accession.version numbers must be included in the text of the article. Example: (GenBank: AI631510.1, GenBank: AI631511.1, GenBank: AI632198.1, and GenBank: BF223228.1), a B-cell tumour from a chronic lymphatic leukaemia (GenBank: BE675048.1), and a T-cell lymphoma (GenBank: AA361117.1). The rs number must be provided for all SNPs/variants where available incl. a description of each variant using genomic coordinates. Example: rs28942083 NC_000019.10:g.11120382G>A http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=28942083
- To describe sequence variants (DNA, RNA & protein), authors should use the recommendations of the HGVS: http://www.hgvs.org/mutnomen/. Tools such as the Mutalyzer software maybe used to assist with this www.mutalyzer.nl
- All data on genes, variants and phenotypes should be deposited in a public repository:
- large rearrangements (CNVs), incl. dbVar, Decipher or LOVD
- gene variant databases, incl. ClinVar and LOVD (databases.http://www.lovd.nl/shared/). Available gene variant database can be identified using the url "GeneSymbol".LOVD.nl (e.g. TP53.LOVD.nl).
- In order to allow for the work to be reproduced by others, where not previously published, authors are encouraged to provide as supplementary material for web-publication only, the primers and PCR conditions for all variants genotyped in the manuscript.
Immediately after the abstract, provide a maximum of 6 keywords, using American spelling and avoiding general and plural terms and multiple concepts (avoid, for example, 'and', 'of'). Be sparing with abbreviations: only abbreviations firmly established in the field may be eligible. These keywords will be used for indexing purposes. Abbreviations
Define abbreviations that are not standard in this field in a footnote to be placed on the first page of the article. Such abbreviations that are unavoidable in the abstract must be defined at their first mention there, as well as in the footnote. Ensure consistency of abbreviations throughout the article. Acknowledgements
Collate acknowledgements in a separate section at the end of the article before the references and do not, therefore, include them on the title page, as a footnote to the title or otherwise. List here those individuals who provided help during the research (e.g., providing language help, writing assistance or proof reading the article, etc.). Formatting of funding sources
List funding sources in this standard way to facilitate compliance to funder's requirements:
Funding: This work was supported by the National Institutes of Health [grant numbers xxxx, yyyy]; the Bill & Melinda Gates Foundation, Seattle, WA [grant number zzzz]; and the United States Institutes of Peace [grant number aaaa].
It is not necessary to include detailed descriptions on the program or type of grants and awards. When funding is from a block grant or other resources available to a university, college, or other research institution, submit the name of the institute or organization that provided the funding.
If no funding has been provided for the research, it is recommended to include the following sentence:
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. Units
Follow internationally accepted rules and conventions: use the international system of units (SI). If other units are mentioned, please give their equivalent in SI. Math formulae
Please submit math equations as editable text and not as images. Present simple formulae in line with normal text where possible and use the solidus (/) instead of a horizontal line for small fractional terms, e.g., X/Y. In principle, variables are to be presented in italics. Powers of e are often more conveniently denoted by exp. Number consecutively any equations that have to be displayed separately from the text (if referred to explicitly in the text). Footnotes
Footnotes should be used sparingly. Number them consecutively throughout the article. Many word processors can build footnotes into the text, and this feature may be used. Otherwise, please indicate the position of footnotes in the text and list the footnotes themselves separately at the end of the article. Do not include footnotes in the Reference list. Artwork Electronic artworkGeneral points
• Make sure you use uniform lettering and sizing of your original artwork.
• Embed the used fonts if the application provides that option.
• Aim to use the following fonts in your illustrations: Arial, Courier, Times New Roman, Symbol, or use fonts that look similar.
• Number the illustrations according to their sequence in the text.
• Use a logical naming convention for your artwork files.
• Provide captions to illustrations separately.
• Size the illustrations close to the desired dimensions of the published version.
• Submit each illustration as a separate file.
• Ensure that color images are accessible to all, including those with impaired color vision.
A detailed guide on electronic artwork
is available.You are urged to visit this site; some excerpts from the detailed information are given here.Formats
If your electronic artwork is created in a Microsoft Office application (Word, PowerPoint, Excel) then please supply 'as is' in the native document format.
Regardless of the application used other than Microsoft Office, when your electronic artwork is finalized, please 'Save as' or convert the images to one of the following formats (note the resolution requirements for line drawings, halftones, and line/halftone combinations given below):
EPS (or PDF): Vector drawings, embed all used fonts.
TIFF (or JPEG): Color or grayscale photographs (halftones), keep to a minimum of 300 dpi.
TIFF (or JPEG): Bitmapped (pure black & white pixels) line drawings, keep to a minimum of 1000 dpi.
TIFF (or JPEG): Combinations bitmapped line/half-tone (color or grayscale), keep to a minimum of 500 dpi.Please do not:
• Supply files that are optimized for screen use (e.g., GIF, BMP, PICT, WPG); these typically have a low number of pixels and limited set of colors;
• Supply files that are too low in resolution;
• Submit graphics that are disproportionately large for the content. Color artwork
Please make sure that artwork files are in an acceptable format (TIFF (or JPEG), EPS (or PDF), or MS Office files) and with the correct resolution. If, together with your accepted article, you submit usable color figures then Elsevier will ensure, at no additional charge, that these figures will appear in color online (e.g., ScienceDirect and other sites) regardless of whether or not these illustrations are reproduced in color in the printed version. For color reproduction in print, you will receive information regarding the costs from Elsevier after receipt of your accepted article
. Please indicate your preference for color: in print or online only. Further information on the preparation of electronic artwork
. Figure captions
Ensure that each illustration has a caption. Supply captions separately, not attached to the figure. A caption should comprise a brief title (not
on the figure itself) and a description of the illustration. Keep text in the illustrations themselves to a minimum but explain all symbols and abbreviations used. Tables
Please submit tables as editable text and not as images. Tables can be placed either next to the relevant text in the article, or on separate page(s) at the end. Number tables consecutively in accordance with their appearance in the text and place any table notes below the table body. Be sparing in the use of tables and ensure that the data presented in them do not duplicate results described elsewhere in the article. Please avoid using vertical rules and shading in table cells. References Citation in text
Please ensure that every reference cited in the text is also present in the reference list (and vice versa). Any references cited in the abstract must be given in full. Unpublished results and personal communications are not recommended in the reference list, but may be mentioned in the text. If these references are included in the reference list they should follow the standard reference style of the journal and should include a substitution of the publication date with either 'Unpublished results' or 'Personal communication'. Citation of a reference as 'in press' implies that the item has been accepted for publication. Reference links
Increased discoverability of research and high quality peer review are ensured by online links to the sources cited. In order to allow us to create links to abstracting and indexing services, such as Scopus, Crossref and PubMed, please ensure that data provided in the references are correct. Please note that incorrect surnames, journal/book titles, publication year and pagination may prevent link creation. When copying references, please be careful as they may already contain errors. Use of the DOI is highly encouraged.
A DOI is guaranteed never to change, so you can use it as a permanent link to any electronic article. An example of a citation using DOI for an article not yet in an issue is: VanDecar J.C., Russo R.M., James D.E., Ambeh W.B., Franke M. (2003). Aseismic continuation of the Lesser Antilles slab beneath northeastern Venezuela. Journal of Geophysical Research, https://doi.org/10.1029/2001JB000884. Please note the format of such citations should be in the same style as all other references in the paper. Web references
As a minimum, the full URL should be given and the date when the reference was last accessed. Any further information, if known (DOI, author names, dates, reference to a source publication, etc.), should also be given. Web references can be listed separately (e.g., after the reference list) under a different heading if desired, or can be included in the reference list. Data references
This journal encourages you to cite underlying or relevant datasets in your manuscript by citing them in your text and including a data reference in your Reference List. Data references should include the following elements: author name(s), dataset title, data repository, version (where available), year, and global persistent identifier. Add [dataset] immediately before the reference so we can properly identify it as a data reference. The [dataset] identifier will not appear in your published article. Preprint references
Where a preprint has subsequently become available as a peer-reviewed publication, the formal publication should be used as the reference. If there are preprints that are central to your work or that cover crucial developments in the topic, but are not yet formally published, these may be referenced. Preprints should be clearly marked as such, for example by including the word preprint, or the name of the preprint server, as part of the reference. The preprint DOI should also be provided. References in a special issue
Please ensure that the words 'this issue' are added to any references in the list (and any citations in the text) to other articles in the same Special Issue. Reference management software
Most Elsevier journals have their reference template available in many of the most popular reference management software products. These include all products that support Citation Style Language styles
, such as Mendeley
. Using citation plug-ins from these products, authors only need to select the appropriate journal template when preparing their article, after which citations and bibliographies will be automatically formatted in the journal's style. If no template is yet available for this journal, please follow the format of the sample references and citations as shown in this Guide. If you use reference management software, please ensure that you remove all field codes before submitting the electronic manuscript. More information on how to remove field codes from different reference management software
. Reference styleText:
Indicate references by number(s) in square brackets in line with the text. The actual authors can be referred to, but the reference number(s) must always be given.
Example: '..... as demonstrated [3,6]. Barnaby and Jones  obtained a different result ....' List:
Number the references (numbers in square brackets) in the list in the order in which they appear in the text. Examples:
Reference to a journal publication:
 J. van der Geer, J.A.J. Hanraads, R.A. Lupton, The art of writing a scientific article, J. Sci. Commun. 163 (2010) 51–59. https://doi.org/10.1016/j.Sc.2010.00372.
Reference to a journal publication with an article number:
 J. van der Geer, J.A.J. Hanraads, R.A. Lupton, 2018. The art of writing a scientific article. Heliyon. 19, e00205. https://doi.org/10.1016/j.heliyon.2018.e00205.
Reference to a book:
 W. Strunk Jr., E.B. White, The Elements of Style, fourth ed., Longman, New York, 2000.
Reference to a chapter in an edited book:
 G.R. Mettam, L.B. Adams, How to prepare an electronic version of your article, in: B.S. Jones, R.Z. Smith (Eds.), Introduction to the Electronic Age, E-Publishing Inc., New York, 2009, pp. 281–304.
Reference to a website:
 Cancer Research UK, Cancer statistics reports for the UK. http://www.cancerresearchuk.org/aboutcancer/statistics/cancerstatsreport/, 2003 (accessed 13 March 2003).
Reference to a dataset:
[dataset]  M. Oguro, S. Imahiro, S. Saito, T. Nakashizuka, Mortality data for Japanese oak wilt disease and surrounding forest compositions, Mendeley Data, v1, 2015. https://doi.org/10.17632/xwj98nb39r.1.
Reference to software:
 E. Coon, M. Berndt, A. Jan, D. Svyatsky, A. Atchley, E. Kikinzon, D. Harp, G. Manzini, E. Shelef, K. Lipnikov, R. Garimella, C. Xu, D. Moulton, S. Karra, S. Painter, E. Jafarov, S. Molins, Advanced Terrestrial Simulator (ATS) v0.88 (Version 0.88), Zenodo, March 25, 2020. https://doi.org/10.5281/zenodo.3727209. Journal abbreviations source
Journal names should be abbreviated according to the List of Title Word Abbreviations
Elsevier accepts video material and animation sequences to support and enhance your scientific research. Authors who have video or animation files that they wish to submit with their article are strongly encouraged to include links to these within the body of the article. This can be done in the same way as a figure or table by referring to the video or animation content and noting in the body text where it should be placed. All submitted files should be properly labeled so that they directly relate to the video file's content. In order to ensure that your video or animation material is directly usable, please provide the file in one of our recommended file formats with a preferred maximum size of 150 MB per file, 1 GB in total. Video and animation files supplied will be published online in the electronic version of your article in Elsevier Web products, including ScienceDirect
. Please supply 'stills' with your files: you can choose any frame from the video or animation or make a separate image. These will be used instead of standard icons and will personalize the link to your video data. For more detailed instructions please visit our video instruction pages
. Note: since video and animation cannot be embedded in the print version of the journal, please provide text for both the electronic and the print version for the portions of the article that refer to this content. Data visualization
Include interactive data visualizations in your publication and let your readers interact and engage more closely with your research. Follow the instructions here
to find out about available data visualization options and how to include them with your article. Supplementary material
Supplementary material such as applications, images and sound clips, can be published with your article to enhance it. Submitted supplementary items are published exactly as they are received (Excel or PowerPoint files will appear as such online). Please submit your material together with the article and supply a concise, descriptive caption for each supplementary file. If you wish to make changes to supplementary material during any stage of the process, please make sure to provide an updated file. Do not annotate any corrections on a previous version. Please switch off the 'Track Changes' option in Microsoft Office files as these will appear in the published version. Research data
This journal encourages and enables you to share data that supports your research publication where appropriate, and enables you to interlink the data with your published articles. Research data refers to the results of observations or experimentation that validate research findings. To facilitate reproducibility and data reuse, this journal also encourages you to share your software, code, models, algorithms, protocols, methods and other useful materials related to the project.
Below are a number of ways in which you can associate data with your article or make a statement about the availability of your data when submitting your manuscript. If you are sharing data in one of these ways, you are encouraged to cite the data in your manuscript and reference list. Please refer to the "References" section for more information about data citation. For more information on depositing, sharing and using research data and other relevant research materials, visit the research data
page. Data linking
If you have made your research data available in a data repository, you can link your article directly to the dataset. Elsevier collaborates with a number of repositories to link articles on ScienceDirect with relevant repositories, giving readers access to underlying data that gives them a better understanding of the research described.
There are different ways to link your datasets to your article. When available, you can directly link your dataset to your article by providing the relevant information in the submission system. For more information, visit the database linking page
For supported data repositories
a repository banner will automatically appear next to your published article on ScienceDirect.
In addition, you can link to relevant data or entities through identifiers within the text of your manuscript, using the following format: Database: xxxx (e.g., TAIR: AT1G01020; CCDC: 734053; PDB: 1XFN). Research Elements
This journal enables you to publish research objects related to your original research – such as data, methods, protocols, software and hardware – as an additional paper in a Research Elements journal
Research Elements is a suite of peer-reviewed, open access journals which make your research objects findable, accessible and reusable. Articles place research objects into context by providing detailed descriptions of objects and their application, and linking to the associated original research articles. Research Elements articles can be prepared by you, or by one of your collaborators.
During submission, you will be alerted to the opportunity to prepare and submit a manuscript to one of the Research Elements journals.
More information can be found on the Research Elements page
. Data statement
To foster transparency, we encourage you to state the availability of your data in your submission. This may be a requirement of your funding body or institution. If your data is unavailable to access or unsuitable to post, you will have the opportunity to indicate why during the submission process, for example by stating that the research data is confidential. The statement will appear with your published article on ScienceDirect. For more information, visit the Data Statement page
Proofs will be sent to the authors to be carefully checked for printer's errors. Changes or additions to the edited manuscript cannot be allowed at this stage. Corrected proofs should be returned to the publisher within 2 days of receipt. Online proof correction
To ensure a fast publication process of the article, we kindly ask authors to provide us with their proof corrections within two days. Corresponding authors will receive an e-mail with a link to our online proofing system, allowing annotation and correction of proofs online. The environment is similar to MS Word: in addition to editing text, you can also comment on figures/tables and answer questions from the Copy Editor. Web-based proofing provides a faster and less error-prone process by allowing you to directly type your corrections, eliminating the potential introduction of errors.
If preferred, you can still choose to annotate and upload your edits on the PDF version. All instructions for proofing will be given in the e-mail we send to authors, including alternative methods to the online version and PDF.
We will do everything possible to get your article published quickly and accurately. Please use this proof only for checking the typesetting, editing, completeness and correctness of the text, tables and figures. Significant changes to the article as accepted for publication will only be considered at this stage with permission from the Editor. It is important to ensure that all corrections are sent back to us in one communication. Please check carefully before replying, as inclusion of any subsequent corrections cannot be guaranteed. Proofreading is solely your responsibility. Offprints
The corresponding author will, at no cost, receive a customized Share Link
providing 50 days free access to the final published version of the article on ScienceDirect
. The Share Link can be used for sharing the article via any communication channel, including email and social media. For an extra charge, paper offprints can be ordered via the offprint order form which is sent once the article is accepted for publication. Corresponding authors who have published their article gold open access do not receive a Share Link as their final published version of the article is available open access on ScienceDirect and can be shared through the article DOI link.
Visit the Elsevier Support Center
to find the answers you need. Here you will find everything from Frequently Asked Questions to ways to get in touch.
You can also check the status of your submitted article
or find out when your accepted article will be published